Walgreen (NYSE:WAG) on Wednesday posted a 2.8% increase in same-store sales for the month of May as more customers filled prescriptions after years of cautious spending during the recession.
Continue Reading Below
However, sales for the third quarter, while up 3.3% to $18.34 billion from $17.75 billion a year ago, fell slightly below average analyst estimates of $18.49 billion, according to a Thomson Reuters poll.
The narrow miss was partially a reflection of virtually flat front-end same-store sales for the quarter that could not be wholly offset by a 7% rise in prescriptions filled. Customer traffic slumped 3.5%, partly offset by a 4.7% rise in average basket size.
The pharmacy business continues to show improvement, and Walgreen said it accounted for 63% of Walgreen’s total sales for the month.
Total sales grew 4.3% to $6.22 billion from $5.97 billion in the year-earlier period as prescriptions filled increased by 7.1%.
Shares of Walgreen increased slightly in premarket trade, and they have risen close to 30% since the beginning of January.